The aim of µFluFarma project is the development of a microfluidic platform for anti-osteoporosis drug screening with strontium ranelate. In particular, the device will consist of a microchannel network for the delivery and mixing of the chemical species, in order to provide a controlled drug gradient to different cell cultures. In this work, we present a bioaffinity study with the aim of evaluating, among the candidate polymeric substrates employed in soft lithography, the most suitable materials for in vitro cell assays.
A microfluidic platform for anti-osteoporosis drug screening: biocompatibility study of polymeric materials
Ress, Cristina;Tindiani, Andrea;Morganti, Elisa;Collini, Cristian;Lorenzelli, Leandro;
2010-01-01
Abstract
The aim of µFluFarma project is the development of a microfluidic platform for anti-osteoporosis drug screening with strontium ranelate. In particular, the device will consist of a microchannel network for the delivery and mixing of the chemical species, in order to provide a controlled drug gradient to different cell cultures. In this work, we present a bioaffinity study with the aim of evaluating, among the candidate polymeric substrates employed in soft lithography, the most suitable materials for in vitro cell assays.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
SIB2010_A microfludic platform for drug screening.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
147.8 kB
Formato
Adobe PDF
|
147.8 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
